(43 days)
These gloves are intended to be worn by operating room personnel to protect a surgical wound from contamination in environments within hospitals and other healthcare facilities. The gloves are appropriate for use during invasive as well as non-invasive medical procedures requiring sterility. These gloves contain 50 micrograms or less of water extractable protein per gram.
Protegrity Blue Latex / Nitrile Surgical Gloves with Neu-Thera are formulated using Natural Rubber Latex. These are offered powder-free and sterile.
Here's a breakdown of the acceptance criteria and study information for the Protegrity Blue Latex / Nitrile Surgical Gloves with Neu-Thera, based on the provided document:
1. Table of Acceptance Criteria and Reported Device Performance
| Test | Acceptance Criteria (from predicate/standard) | Reported Device Performance |
|---|---|---|
| Primary Skin Irritation | Not explicitly stated as a numerical criterion, but implies non-irritating. | Gloves are non-irritating. |
| Guinea Pig Maximization | Not explicitly stated as a numerical criterion, but implies no sensitization potential. | Gloves do not display any potential for sensitization. |
| Ultimate Elongation & Tensile Strength | Requirements for rubber surgical gloves per ASTM D3577-01ae2. | Gloves exceed requirements for rubber surgical gloves per ASTM D3577-01ae2. |
| Barrier Defects (AQL) | Requirements per 21 CFR §800.20 and ASTM D3577-01ae2, AQL = 1.5. | Gloves exceed requirements per 21 CFR §800.20 and ASTM D3577-01ae2, AQL = 1.5. |
| Powder Level (for "Powder Free" designation) | Below 2 mg of residual powder per glove (ASTM Standard D6124-01). | Results generated values below 2 mg of residual powder per glove, meeting powder level requirements for "Powder Free" designation using ASTM Standard D6124-01. |
| Water Extractable Protein | 50 micrograms or less of water extractable protein per gram. | These latex gloves contain 50 micrograms or less of water extractable protein per gram. (Stated in intended use and claims). No specific "reported performance" value given, but claimed to meet the limit. |
2. Sample Size Used for the Test Set and Data Provenance
The document does not specify a distinct "test set" in the context of device performance in a clinical study as one would expect for an AI/diagnostic device. The testing described is primarily for material properties and biological reactivity.
- For physical and biological testing (Primary Skin Irritation, Guinea Pig Maximization, Ultimate Elongation & Tensile Strength, Barrier Defects, Powder Level), the sample sizes are not explicitly stated in the provided text. These tests are typically performed on representative batches of gloves according to relevant ASTM or ISO standards.
- The data provenance is from the manufacturer's internal testing (Cardinal Health), related to the manufacturing and design of the surgical gloves. It is retrospective in the sense that the data supports the premarket notification for a device that is about to be marketed, rather than being part of a prospective clinical trial.
3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts
This information is not applicable to the type of device and testing described. Surgical gloves do not typically involve expert interpretation of results to establish "ground truth" in the way a diagnostic imaging device would. The "ground truth" for the performance criteria (e.g., tensile strength, protein levels, barrier integrity) is established by the standardized test methods themselves and their quantitative outputs, rather than by expert consensus.
4. Adjudication Method for the Test Set
Not applicable for this type of device and testing. Adjudication methods (like 2+1, 3+1) are used for resolving discrepancies in expert interpretations, which is not relevant here.
5. If a Multi Reader Multi Case (MRMC) Comparative Effectiveness Study Was Done, If So, What Was the Effect Size of How Much Human Readers Improve with AI vs Without AI Assistance
Not applicable. This is a surgical glove, not an AI-assisted diagnostic device. Therefore, no MRMC study with human readers and AI assistance was performed.
6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Was Done
Not applicable. This is a physical medical device (surgical glove), not an algorithm or AI system.
7. The Type of Ground Truth Used (expert consensus, pathology, outcomes data, etc.)
The ground truth for the device's performance is based on:
- Standardized Test Methods: Adherence to established ASTM (American Society for Testing and Materials) standards (e.g., D3577-01ae2 for rubber surgical gloves, D6124-01 for residual powder).
- Regulatory Requirements: Compliance with regulations outlined in 21 CFR (e.g., §800.20 for barrier defects) and the general requirements for medical devices.
- Quantitative Measurements: Direct measurements of physical properties (tensile strength, elongation), chemical properties (protein levels), and biological responses (irritation, sensitization potential) as defined by the test methods.
8. The Sample Size for the Training Set
Not applicable. This is a physical device, not a machine learning model, so there is no concept of a "training set."
9. How the Ground Truth for the Training Set Was Established
Not applicable, as there is no training set for this device.
{0}------------------------------------------------
Image /page/0/Picture/1 description: The image shows the logo for Cardinal Health. The logo consists of a stylized graphic of several curved lines above the company name. The text "CardinalHealth" is written in a bold, sans-serif font.
JAN 5 -2006
SUMMARY OF SAFETY AND EFFECTIVENESS As required by §807.92(c)
510(k) SUMMARY OF SAFETY AND EFFECTIVENESS PROTEGRITY BLUE LATEX / NITRILE SURGICAL GLOVES WITH NEU THERA
| Regulatory Affairs Contact: | Amy HoydCardinal Health1500 Waukegan Road, MP-WMMcGaw Park, IL 60085 |
|---|---|
| Telephone: | (847) 578.2325 |
| Fax: | (847) 785-2461 |
| Date Summary Prepared: | 11/14/05 |
| Product Trade Name: | Protegrity Blue with Neu-Thera |
| Common Name: | Surgical Glove |
| Classification: | Glove, Surgeon's |
| Predicate Devices: | Cardinal Health's Protegrity Micro Sterile LatexSurgical Gloves (K001924) |
| Description: | Protegrity Blue Latex / Nitrile Surgical Gloves withNeu-Thera are formulated using Natural RubberLatex. These are offered powder-free and sterile. |
| Intended Use: | Protegrity Blue Latex / Nitrile Surgical Gloves withNeu-Thera are intended for use in environmentswithin hospitals and other healthcare facilities. Thegloves are appropriate for use during invasive andnon-invasive medical procedures requiring sterility.They are intended to be worn by operating roompersonnel to protect a surgical wound fromcontamination. These latex gloves contain 50micrograms or less of water extractable protein pergram. |
{1}------------------------------------------------
Image /page/1/Picture/1 description: The image contains the logo for Cardinal Health. The logo consists of a stylized graphic above the company name. The graphic is composed of several curved lines that converge at a point, resembling a bird in flight or abstract wings. The text "CardinalHealth" is written in a bold, sans-serif font, with the first letter of each word capitalized.
SUMMARY OF SAFETY AND EFFECTIVENESS As required by §807.92(c)
510(k) SUMMARY OF SAFETY AND EFFECTIVENESS PROTEGRITY BLUE LATEX / NITRILE SURGICAL GLOVES WITH NEU-THERA continued
| Substantial Equivalence: Protegrity Blue Latex / Nitrile Surgical Gloves with Neu-Thera are substantially equivalent to Protegrity Micro SterileLatex Surgical Gloves in that they provide the followingcharacteristics:- same intended use |
|---|
- same sizes, product features
- both made of Natural Rubber Latex using similar manufacturing process
Summary of Testing:
| Test | Result |
|---|---|
| Primary Skin Irritation | Gloves are non-irritating. |
| Guinea Pig Maximization | Gloves do not display any potential for sensitization. |
| Ultimate Elongation& Tensile Strength | Gloves exceed requirements for rubber surgical glovesper ASTM D3577-01ae2. |
| Barrier Defects | Gloves exceed requirements per 21 CFR§800.20 and ASTM D3577-01ae2, AQL = 1.5. |
| Data/Test Method | Gloves meet powder level requirements for "Powder Free"designation using ASTM Standard D6124-01-Standard testmethod for residual powder on medical gloves. Resultsgenerated values below 2 mg of residual powder per glove. |
{2}------------------------------------------------
Image /page/2/Picture/0 description: The image shows the logo for Cardinal Health. The logo consists of a stylized graphic of four curved lines above the company name. The company name is written in a sans-serif font, with the words "Cardinal" and "Health" joined together.
SUMMARY OF SUBSTANTIAL EQUIVALENCE CON'T 510(k) S. E. DECISION SUMMARY PROTEGRITY MICRO STERILE LATEX SURGICAL GLOVES (K001924) vs. PROTEGRITY BLUE LATEX / NITRILE SURGICAL GLOVES WITH NEU-THERA
QUESTION
SUMMARY RESPONSE
REFERENCE
KO53272
| 3. Does new device havesame indicationstatements? | YES: Protegrity Blue Latex Surgical Glove with Neu-Thera has the identical intended use as Protegrity MicroSterile Latex Surgical glove. Both are intended to beworn by operating room personnel to protect a surgicalwound from contamination. | Page 16-17 |
|---|---|---|
| 5. Does new device havesame technologicalcharacteristics? | YES: The answer is Yes for the following:a) Coated Gloves and Protegrity Gloves are madefrom a similar latex slurry and coagulantformulation.b) Both gloves are similar with regard to design,namely size, physical form and hand specificnature.c) Both gloves are comparable with respect to therequirements outlined in ASTM D3577-01ae2d) Both gloves are sterile, powder-free and havethe protein labeling claim.e) Both gloves are lubricated with CPC, silicone.f) Both gloves have beaded cuffs.g) Both gloves are made using triple dippingtechnology that includes a nitrile coating. | Page 16-17 andAttachment J |
| NO: The answer is No for the following:a) The colorants used in the manufacturingprocess of the two products are different.b) Neu-Thera Gloves are coated with PolymericAmino Sugar, Deacetylated Chitin (HydagenCMF), Citric Acid, Glycerol, D-Sorbitol, ProvitaminB-5 (Ritapan DL) , Glucono-delta-lactone(Glucono-d-lactone), Triethyl Citrate (HydagenCAT), Sodium Citrate Dihydrate and Ammoniumsalts of alkyl phosphate (Darvan L) | Pages 16-17 andAttachment J | |
| 7. Are the descriptivecharacteristics preciseenough to ensureequivalency? | YES: The physical testing performed indicates that theproduct is acceptable. The predicate device comparisontable outlines the critical parameters of both gloves.Given the products intended use, the descriptivecharacteristics adequately demonstrate equivalency. | Pages 16-17 andAttachment J |
{3}------------------------------------------------
Image /page/3/Picture/0 description: The image shows the logo for Cardinal Health. The logo consists of a stylized graphic above the company name. The graphic is composed of several curved lines that converge towards the left, resembling abstract wings or paths.
MANUFACTURE'S STATEMENT OF SUBSTANTIAL EQUIVALENCE
(To be provided with 510(k) notifications for tier 1 devices)
003272
STATEMENT OF INDICATIONS FOR USE:
Protegrity Blue Latex / Nitrile Surgical Gloves with Neu-Thera are designed for use during invasive and non-invasive medical procedures requiring sterility. They are designed to be worn by operating room personnel to protect a surgical wound from contamination. These latex gloves contain 50 ming rooms or less of water extractable protein per gram.
CLAIMS:
Protegrity Blue Latex / Nitrile Surgica! Gloves with Neu-Thera:
Sterile, powder-free, for single use only, contains natural rubber latex
-
- Sterile, powder-free, for single use only
-
- This latex glove contains 50 micrograms or less of total water extractable protein per gram
-
- Glove provides superior wet donning properties for easy donning
This notification contains all of the information required by 21 CFR §807.87. A completed copy of the "Premarket Notification 510(k) Reviewer's Screening Checklist" is included with this submission.
The subject device conforms to the following voluntary and mandatory standards:
Good Manufacturing Practices, ASTM Standard D3577-99.
The subject device has the same technological characteristics as a legally marketed predicate device. Specifically, the features, specifications, materials, and intended use are equivalent.
The above statements are accurate representations of this 510(k) premarket notification and of the device this firm intends to market. All data and information submitted in this premarket notification is truthful and accurate and no material fact has been omitted (21 CFR §807.87 (j)).
MANUFACTURER:
CARDINAL HEALTH
OFFICIAL CORRESPONDENT:
Amy Heipl
Amy Hoyd (printed name) TITLE: Regulatory Affairs Manager DATE: 26, December 2005
{4}------------------------------------------------
Image /page/4/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo is circular and contains the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. In the center of the circle is a stylized symbol that resembles three overlapping lines or stripes, possibly representing an abstract human figure or a symbol of health and well-being.
Public Health Service
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
JAN 5 2006
Cardinal Health C/O Ms. Amy Hoyd Regulatory Affairs Manager Medical Products and Services 1500 Waukegan Road McGaw Park, Illinois 60085
Re: K053272
Trade/Device Name: Protegrity Sterile Latex/Nitrile Surgical Gloves with Blue Colorant and Neu-Thera Proprietary Coating (Containing Chitosan, ProVitamin B5, Gluconolactone and Glycerol) and Protein Labeling Claim of 50 Micrograms or Less Regulation Number: 878.4460 Regulation Name: Surgeon's Glove Regulatory Class: I Product Code: KGO Dated: November 16, 2005 Received: December 13, 2005
Dear Ms. Hoyd:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
{5}------------------------------------------------
Page 2 - Ms. Hoyd
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration
and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely vours.
Smutie y. Michael Oms.
Chiu Lin, Ph.D. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{6}------------------------------------------------
Image /page/6/Picture/0 description: The image shows the logo for Cardinal Health. The logo consists of a stylized graphic above the company name. The graphic is composed of three curved lines that resemble abstract bird wings or flight paths. The text "CardinalHealth" is written in a simple, sans-serif font, with the first letter capitalized and the rest in lowercase.
1500 Waukegan Road McGaw Park, Illinois 60085-6787 FAX 847 785 2460
3.0 Indications for Use Statement
510(k) Number: (if known): K053272
- Device Name: Protegrity Sterile Latex/Nitrile Surgical Gloves with blue colorant and Neu-Thera proprietary coating (containing Chitosan, ProVitamin B5, Gluconolactone and Glycerol) and protein labeling claim of 50 micrograms or less. Indications For Use: These gloves are intended to be worn by operating room personnel to protect a surgical wound from contamination in environments within hospitals and other healthcare facilities. The gloves are appropriate for use during invasive as well as non-invasive medical procedures requiring sterility. These gloves contain 50 micrograms or less of water extractable protein per gram.
Prescription Use Over-The Counter Use AND/OR × ( 21 CFR 801 Subpart D) (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE
Concurrence of CDRH, Office of Device Evaluation (ODE)
Shuly A. Murphy, B. 1/4/04
General Hospital
Dental Devices
K 053272
Page 4 of 21
Page 1 of
§ 878.4460 Non-powdered surgeon's glove.
(a)
Identification. A non-powdered surgeon's glove is a device intended to be worn on the hands of operating room personnel to protect a surgical wound from contamination. A non-powdered surgeon's glove does not incorporate powder for purposes other than manufacturing. The final finished glove includes only residual powder from manufacturing.(b)
Classification. Class I (general controls).